scholarly journals History and development of national burden of disease assessment in Australia

2020 ◽  
Vol 78 (1) ◽  
Author(s):  
Lynelle Moon ◽  
Michelle Gourley ◽  
John Goss ◽  
Miriam Lum On ◽  
Paula Laws ◽  
...  
Keyword(s):  
Burden Of Disease ◽  
World Health ◽  
Disease Assessment ◽  
Disability Adjusted Life ◽  
The World ◽  
National Burden ◽  
Quality Framework ◽  
Health Organization ◽  
Disease Study ◽  
Disability Adjusted Life Year

Abstract Australia’s 1996 national burden of disease (BoD) study was one of the first in the world and updates have continued over the following two decades with the fifth study now underway. The studies adapt the global framework most recently implemented by the Global Burden of Disease Study and the World Health Organization to suit Australia’s specific needs, producing estimates of fatal and non-fatal burden via the Disability Adjusted Life Year (DALY) metric, as well as attribution of the burden to many risk factors. Detailed Australian data are used with minimal reliance on modelling to fill data gaps. Comprehensive estimates are produced, including for the Indigenous population, for each of the eight states and territories, the five remoteness areas and five socioeconomic quintiles. A number of method developments have been made as part of these studies, including redistribution of deaths data and a detailed quality framework for describing the robustness of the underlying data and methods. Data and methods continue to be refined as part of the studies, and developments in global studies and other national studies are incorporated where appropriate.

Key developments and results from the Australian Burden of Disease Study

2020 ◽  
Vol 30 (Supplement_5) ◽  
Author(s):  
M Gourley ◽  
R Juckes ◽  
L Moon
Keyword(s):  
Burden Of Disease ◽  
Lessons Learned ◽  
Global Studies ◽  
Disability Adjusted Life ◽  
Data Gaps ◽  
National Burden ◽  
History Of ◽  
Quality Framework ◽  
Disease Study ◽  
Disability Adjusted Life Year

Abstract Australia has been at the forefront of national burden of disease study development for more than 20 years. Australia's 1996 national burden of disease study was one of the first in the world and updates have continued over the following two decades with the fifth study now underway. The studies adapt the global framework most recently implemented by the Global Burden of Disease Study to suit Australia's specific needs, producing estimates of fatal and non-fatal burden via the Disability-Adjusted-Life-Year metric, as well as attribution of the burden to many risk factors. Detailed Australian data are used from a range of sources (e.g. death registrations, population surveys, disease registers, hospitalisations and linked health data) with minimal reliance on modelling to fill data gaps. Comprehensive burden of disease estimates are produced, including for the Indigenous population, for each of the eight states and territories, the five remoteness areas and five socioeconomic quintiles. A number of method developments have been made as part of these studies, including redistribution of deaths data and a detailed quality framework for describing the robustness of the underlying data and methods. Data and methods continue to be refined as part of the studies, and developments in global studies and other national studies are incorporated where appropriate. This presentation will describe the history of burden of disease work in Australia, including some of the key method developments made, challenges faced over the years and lessons learned. It will also present some key results from the latest Australian Burden of Disease Study (2015) and how these estimates are being used for population health monitoring, health policy and research in Australia.

scholarly journals The burden of musculoskeletal disorders in the countries of the Eastern Mediterranean region of the World Health Organization (EMRO): Study period 2000-2017

2021 ◽  
Author(s):  
Jafar Yahyavi Dizaj ◽  
Manijeh Soleimanifar ◽  
Reza Hashempour ◽  
Ali Kazemi Karyani ◽  
Fateh Mohsen ◽  
...  
Keyword(s):  
Low Back Pain ◽  
Back Pain ◽  
Neck Pain ◽  
Musculoskeletal Disorders ◽  
Burden Of Disease ◽  
Disease Burden ◽  
World Health ◽  
Low Back ◽  
The World ◽  
Health Organization

Abstract Background: MSK health is imperative for the active participation of an individual in society and MSK related disorders more direly affects a person's quality of life compared other non-communicable disease while it also negatively effects the health system and economy of a country. The current manuscript analyzed and describes the disease burden of MSK disorders in the EMRO region.Methods: This was a cross-sectional descriptive-analytical study conducted based on data published by the Global Burden of Disease Database for MSK disorders up to 2017. The study target comprised population from all countries of the EMRO region of World Health Organization. The present study considered, MSK disorders such as (rheumatoid arthritis), (osteoarthritis), (Low back pain), (neck pain), (gout) and (other Musculoskeletal disorders. The DALY index was used to measure total disease burden.Results: MSK disorders in the world and in the EMRO region was ranked 5th (4% of total disease burden) and 7th (5% of total disease burden) among all diseases in 2017, respectively. Women over 30 years of age in the EMRO region had the highest risk of MSK disorders compared to other regions and in addition, the DALY lost in EMRO region due to MSK disorders was higher in women of all age categories than men. According to the results of this study, Low back pain, Other musculoskeletal disorders and Neck pain had the highest prevalence and burden of disease in the EMRO region and the world. Bahrain, Iran, and Morocco had the highest incidence of MSK DALY score in the EMRO region, and Somalia, Djibouti, and Afghanistan had the lowest incidence of MSK disorders and DALY score, respectively.Conclusion: With the increase in geriatric population and obesity especially in developing countries, consequently, more people tend to suffer from MSK disorders and it is predicted that this spike will continue in the coming decades. Taking in to account the high prevalence and burden of MSK disorders, forces government and health-policy makers to focus more on preventive cares and rehabilitation.

Global, regional, and national burden of other musculoskeletal disorders 1990–2017: results from the Global Burden of Disease Study 2017

Rheumatology ◽  
2020 ◽  
Author(s):  
Saeid Safiri ◽  
Ali Asghar Kolahi ◽  
Marita Cross ◽  
Kristin Carson-Chahhoud ◽  
Amir Almasi-Hashiani ◽  
...  
Keyword(s):  
Burden Of Disease ◽  
National Level ◽  
Point Prevalence ◽  
Global Burden Of Disease ◽  
Global Burden ◽  
Disability Adjusted Life ◽  
Life Years ◽  
Prevalence Estimates ◽  
National Burden ◽  
Disease Study

Abstract Objectives To describe the level and trends of point prevalence, deaths and disability-adjusted life years (DALYs) for other musculoskeletal (MSK) disorders, i.e. those not covered by specific estimates generated for RA, OA, low back pain, neck pain and gout, from 1990 to 2017 by age, sex and sociodemographic index. Methods Publicly available modelled estimates from the Global Burden of Disease (GBD) 2017 study were extracted and reported as counts and age-standardized rates per 100 000 population for 195 countries and territories between 1990 and 2017. Results Globally, the age-standardized point prevalence estimates and deaths rates of other MSK disorders in 2017 were 4151.1 and 1.0 per 100 000. This was an increase of 3.4% and 7.2%, respectively. The age-standardized DALY rate in 2017 was 380.2, an increase of 3.4%. The point prevalence estimate was higher among females and increased with age. This peaked in the 65–69 year age group for both females and males in 2017, followed by a decreasing trend for both sexes. At the national level, the highest age-standardized point prevalence estimates in 2017 were seen in Bangladesh, India and Nepal. The largest increases in age-standardized point prevalence estimates were observed in Romania, Croatia and Armenia. Conclusion The burden of other MSK disorders is proven to be substantial and increasing worldwide, with a notable intercountry variation. Data pertaining to specific diseases within this overarching category are required for future GBD MSK estimates. This would enable policymakers to better allocate resources and provide interventions appropriately.

scholarly journals Mortality from snakebite envenomation: an analysis from the Global Burden of Disease Study 2019

2021 ◽  
Author(s):  
Nicholas Roberts ◽  
Emily Johnson ◽  
Scott Zeng ◽  
Erin Hamilton ◽  
Amir Abdoli ◽  
...  
Keyword(s):  
Burden Of Disease ◽  
World Health ◽  
Global Burden Of Disease ◽  
Global Burden ◽  
Uncertainty Interval ◽  
Registration Data ◽  
Venomous Animal ◽  
Animal Contact ◽  
Health Organization ◽  
Disease Study

Abstract Venomous snakebite is an important cause of preventable death. The World Health Organization (WHO) set a goal to halve snakebite mortality by 2030. We used verbal autopsy and vital registration data to model the proportion of venomous animal deaths due to snakes by location, age, year, and sex, and applied these proportions to venomous animal contact mortality estimates from the Global Burden of Disease 2019 study. In 2019, 63,400 people (95% uncertainty interval 38,900–78,600) died globally from snakebites, which was equal to an age-standardized mortality rate (ASMR) of 0.8 deaths (0.5–1.0) per 100,000 and represents a 36% (2–49) decrease in ASMR since 1990. India had the greatest number of deaths in 2019, equal to an ASMR of 4.0 per 100,000 (2.3-5.0). We forecast mortality will continue to decline, but not sufficiently to meet the WHO’s goals. Improved data collection should be prioritized to help target interventions, improve burden estimation, and monitor progress.

Global Health and the Global Burden of Disease

2017 ◽  
Author(s):  
Joia S. Mukherjee
Keyword(s):  
Burden Of Disease ◽  
Disease Burden ◽  
Morbidity And Mortality ◽  
World Health ◽  
Global Burden Of Disease ◽  
Global Burden ◽  
Health Coverage ◽  
The World ◽  
Health Organization ◽  
Universal Health

This chapter defines terms used to describe the health of populations, such as incidence, prevalence, morbidity, and mortality. It introduces the concept of the burden of disease: that is, the quantity and impact of diseases and conditions that affect the health of populations. The Global Burden of Disease project, first launched in 1990 by the World Health Organization (WHO) seeks to measure disease burden on a regular basis. This chapter also examines the epidemiological transition, a concept that describes changes in causes of morbidity and mortality associated with economic development. The limitations of this concept and the need to address the entirety of the disease burden and achieve Universal Health Coverage are also discussed.

Sign in / Sign up

Export Citation Format

Share Document